246 related articles for article (PubMed ID: 8980230)
1. A cyclin-dependent kinase inhibitor, Dacapo, is necessary for timely exit from the cell cycle during Drosophila embryogenesis.
de Nooij JC; Letendre MA; Hariharan IK
Cell; 1996 Dec; 87(7):1237-47. PubMed ID: 8980230
[TBL] [Abstract][Full Text] [Related]
2. Dacapo, a cyclin-dependent kinase inhibitor, stops cell proliferation during Drosophila development.
Lane ME; Sauer K; Wallace K; Jan YN; Lehner CF; Vaessin H
Cell; 1996 Dec; 87(7):1225-35. PubMed ID: 8980229
[TBL] [Abstract][Full Text] [Related]
3. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.
Toyoshima H; Hunter T
Cell; 1994 Jul; 78(1):67-74. PubMed ID: 8033213
[TBL] [Abstract][Full Text] [Related]
4. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene.
Matsuoka S; Edwards MC; Bai C; Parker S; Zhang P; Baldini A; Harper JW; Elledge SJ
Genes Dev; 1995 Mar; 9(6):650-62. PubMed ID: 7729684
[TBL] [Abstract][Full Text] [Related]
5. Drosophila p27Dacapo expression during embryogenesis is controlled by a complex regulatory region independent of cell cycle progression.
Meyer CA; Kramer I; Dittrich R; Marzodko S; Emmerich J; Lehner CF
Development; 2002 Jan; 129(2):319-28. PubMed ID: 11807025
[TBL] [Abstract][Full Text] [Related]
6. The Drosophila ATM homologue Mei-41 has an essential checkpoint function at the midblastula transition.
Sibon OC; Laurençon A; Hawley R; Theurkauf WE
Curr Biol; 1999 Mar; 9(6):302-12. PubMed ID: 10209095
[TBL] [Abstract][Full Text] [Related]
7. Drosophila fizzy-related down-regulates mitotic cyclins and is required for cell proliferation arrest and entry into endocycles.
Sigrist SJ; Lehner CF
Cell; 1997 Aug; 90(4):671-81. PubMed ID: 9288747
[TBL] [Abstract][Full Text] [Related]
8. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.
Meijer L; Borgne A; Mulner O; Chong JP; Blow JJ; Inagaki N; Inagaki M; Delcros JG; Moulinoux JP
Eur J Biochem; 1997 Jan; 243(1-2):527-36. PubMed ID: 9030781
[TBL] [Abstract][Full Text] [Related]
9. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein.
Zhu X; Ohtsubo M; Böhmer RM; Roberts JM; Assoian RK
J Cell Biol; 1996 Apr; 133(2):391-403. PubMed ID: 8609171
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate.
Liang YC; Lin-Shiau SY; Chen CF; Lin JK
J Cell Biochem; 1999 Oct; 75(1):1-12. PubMed ID: 10462699
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells.
Orend G; Hunter T; Ruoslahti E
Oncogene; 1998 May; 16(20):2575-83. PubMed ID: 9632134
[TBL] [Abstract][Full Text] [Related]
13. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.
Foster JS; Henley DC; Bukovsky A; Seth P; Wimalasena J
Mol Cell Biol; 2001 Feb; 21(3):794-810. PubMed ID: 11154267
[TBL] [Abstract][Full Text] [Related]
14. Expression of the cyclin-dependent kinase inhibitor Dacapo is regulated by cyclin E.
de Nooij JC; Graber KH; Hariharan IK
Mech Dev; 2000 Oct; 97(1-2):73-83. PubMed ID: 11025208
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the embryonic cell proliferation by Drosophila cyclin D and cyclin E complexes.
Lehner CF; Jacobs HW; Sauer K; Meyer CA
Novartis Found Symp; 2001; 237():43-54; discussion 54-7, 93-9. PubMed ID: 11444049
[TBL] [Abstract][Full Text] [Related]
16. Cyclin E2: a novel CDK2 partner in the late G1 and S phases of the mammalian cell cycle.
Lauper N; Beck AR; Cariou S; Richman L; Hofmann K; Reith W; Slingerland JM; Amati B
Oncogene; 1998 Nov; 17(20):2637-43. PubMed ID: 9840927
[TBL] [Abstract][Full Text] [Related]
17. Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines.
Akama Y; Yasui W; Kuniyasu H; Yokozaki H; Akagi M; Tahara H; Ishikawa T; Tahara E
Jpn J Cancer Res; 1996 Aug; 87(8):824-30. PubMed ID: 8797888
[TBL] [Abstract][Full Text] [Related]
18. Formation of p27-CDK complexes during the human mitotic cell cycle.
Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A
Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197
[TBL] [Abstract][Full Text] [Related]
19. A double-assurance mechanism controls cell cycle exit upon terminal differentiation in Drosophila.
Buttitta LA; Katzaroff AJ; Perez CL; de la Cruz A; Edgar BA
Dev Cell; 2007 Apr; 12(4):631-43. PubMed ID: 17419999
[TBL] [Abstract][Full Text] [Related]
20. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.
Koga H; Sakisaka S; Harada M; Takagi T; Hanada S; Taniguchi E; Kawaguchi T; Sasatomi K; Kimura R; Hashimoto O; Ueno T; Yano H; Kojiro M; Sata M
Hepatology; 2001 May; 33(5):1087-97. PubMed ID: 11343236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
